Mode
Text Size
Log in / Sign up
N/A N=12 Other

Portable EMG-triggered Hand Robot for Individuals After Stroke

Stroke

Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Jul 2017
Primary outcome: Primary: Fugl-Meyer Assessment of Upper Extremity (FMA) — 22.50 units on a scale — p=<.05

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Hand of Hope (HOH) (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Rehab-Robotics Company Limited
Primary completion
Jun 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Fugl-Meyer Assessment of Upper Extremity (FMA)
22.50 <.05 sig
PRIMARY
Arm Motor Ability Test (AMAT)
2.35
PRIMARY
Box and Blocks
6.08
SECONDARY
Stroke Upper Limb Capacity Scale (SULCS)
5.17
SECONDARY
Hand Dynamometry
8.23
SECONDARY
Stroke Impact Scale --Hand Sub Scale (SIS-H)
13.33

Summary

This is an interventional pilot study investigating the feasibility of using the hand of hope (HOH) device for individuals with decreased hand function after stroke.

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of stroke > 6 months ago
  • Presence of some active range of motion (AROM) in the affected hand, measured by a score of at least 1 on the Box and Block test.
  • Intact sensation in the affected hand
  • Full passive range of motion (PROM) in mass flexion and extension of the hand
  • MAS score < 3 for finger flexors and intrinsics
  • MAS score < 3 for finger extensors
  • Visual tracking is intact in all directions
  • Patient must be otherwise medically stable in the opinion of the principal investigator

Exclusion Criteria

  • Patient is receiving active occupational or physical therapy for the affected arm
  • Patient has joint contractures that prevent proper fit into the HOH device
  • Patient has other concurrent neurological or orthopedic diagnoses that affect motor ability of the arm such as Parkinson's or Multiple Sclerosis, or arthritis
  • It has been less than 3 months since last botulinum toxin injection in the affected arm
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02364700). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search